Bayer, Sun Pharma sign marketing and distribution pact for second brand of Finerenone
Sun Pharma to market the drug under the brand name Lyvelsa
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Zeon Lifesciences gets patent for ‘synergistic herbal immunomodulatory formulation’
The formulation comprises ingredients that are registered with the FSSAI
Expectations from Budget 2024: Govt must prioritise funds for digital integration in pharma supply…
Saransh Chaudhary, President, Global Critical Care, Venus Remedies, and CEO, Venus Medicine Research Centre (VMRC) also states…
SCHOTT FIOLAX scholarship program celebrates 10-year anniversary
FIOLAX scholarship program supports high potential pharmacy students from over 25 colleges in the Gujarat and Mumbai region
ENTOD Pharma forays into veterinary eye and ear care with ‘FUR’
The product portfolio ranges from lubricating drops to anti-glaucoma medications, anti-allergies, antibiotics, and combinations
From genes to greens: Recombinant revolution in nutraceuticals
Recombinant technology holds transformative potential in nutraceuticals. However, while presenting opportunities for enhanced…
Female contraceptives market still requires therapeutics with better safety profiles: GlobalData
The unmet need for non-hormonal contraception is a significant concern for individuals who wish to avoid hormonal contraceptives…
Unichem gets USFDA nod for Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
Gout market across 7MM set to reach $10.8 bn in 2032 fueled by novel ULTs and rising prevalence:…
There are nine therapies in the late-stage pipeline, most of which are urate-lowering therapies (ULTs) entering the US and Japan…
J&J acquisition of Ambrx bolsters cancer ADC portfolio amidst big pharma’s growing investment…
ADCs continue to be the hot topic in big pharma. Prior to the announced J&J deal, last year alone saw 155 deals struck for the…
Akumentis Healthcare launches Clasepi, synthetic CBD for epilepsy
Clasepi comes with important usage considerations; it is not recommended for individuals allergic to cannabidiol or any of its…
Lupin launches Varenicline Tablets in the US
It is indicated for use as an aid to smoking cessation treatment
Healthcare industry reported 84 deals worth $38.6 billion, in Dec 2023
Deal value increased by 4.4 per cent in Dec 2023, compared to Dec 2022
Supriya Lifescience gets GMP certification from ANVISA Brazil
ANVISA certification will help Supriya Lifescience to strategically grow its footprint in the Brazilian pharmaceutical sector and…
Hikal, Gujarat govt ink MoU at Vibrant Gujarat Summit
Under the terms of the MoU, Hikal invests Rs 500 crores into the existing fine chemical plant at Panoli, Gujarat
Biotech funding recovery is on the horizon in 2024: GlobalData
40 per cent of healthcare industry professionals surveyed globally expressed an optimistic or very optimistic sentiment on the …
UP govt to build a 1472-acre pharma park in Lalitpur, Bundelkhand
The identified villages for the survey include Saidpur (426 acres), Gadolikala (249 acres), Largan (239 acres), Karounda (116…
Lupin launches Second Edition of Aptivate Champion Run for Kids
It promotes children’s well-being through fitness and nutrition
Caplin Steriles gets USFDA approval for Ofloxacin Otic Solution
Ofloxacin Otic Solution 0.3% is used as anti-infective (antibacterial) for otic (ear) use
Akums launches Lasmiditan Tablet for migraine management
The medication is formulated to interrupt pain signals to the brain and address nerve inflammation contributing to migraine…